Medtronic, a medical giant, completed the $50 billion merger and acquisition of Kohei medical

Source: Medtronic, a medical device giant, announced on January 28, 2015 that it had completed the merger and acquisition of Kehui medical company Based on the closing price of $75.59 per share of Medtronic on the 26th, the total value of the cash and stock merger and acquisition transaction is about $49.9 billion Under the terms of the M & a agreement, Medtronic and Kohei medical are merged into Medtronic limited Each of the issued common shares of kohui Medical Co., Ltd has been converted into US $35019 plus 0.956 ordinary shares of Medtronic Co., Ltd as of the closing The issued ordinary shares of Medtronic have been converted into the equity of each ordinary share of Medtronic Co., Ltd Medtronic's shares will then be traded on the New York Stock Exchange Medtronic said the acquisition would not affect its financial results for the third quarter of the financial year ended January 23, 2015 "The completion of the deal is an important milestone in the healthcare industry," said Omar ishrak, chairman and CEO of Medtronic "The fundamental goal of the merger is to address the biggest challenges in the healthcare industry - expanding access, improving healthcare effectiveness and reducing costs." Medtronic Co., Ltd will set up a general administrative office in Ireland, and its operation headquarters will continue to be located in Minneapolis According to reports, Medtronic has more than 85000 employees in more than 160 countries and regions around the world Its products include all-round medical instruments and devices including pacemakers, stents, etc.